Published in Environ Health Perspect on July 01, 1993
Time series analysis of sperm concentration in fertile men in Toulouse, France between 1977 and 1992. BMJ (1996) 2.31
Fertility in mice after prenatal exposure to benzo[a]pyrene and inorganic lead. Environ Health Perspect (1995) 0.92
Comparison of Bayesian and frequentist approaches in modelling risk of preterm birth near the Sydney Tar Ponds, Nova Scotia, Canada. BMC Med Res Methodol (2007) 0.82
Evidence for decreasing quality of semen during past 50 years. BMJ (1992) 17.44
Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet (1993) 12.83
Male reproductive health and environmental xenoestrogens. Environ Health Perspect (1996) 4.11
Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology (2012) 3.98
Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet (1998) 3.34
Regional differences in semen quality in Europe. Hum Reprod (2001) 3.19
Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet (2004) 2.69
Possible carcinoma-in-situ of the testis. Lancet (1972) 2.68
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl (1987) 2.61
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br J Cancer (2003) 2.43
Semen quality of fertile US males in relation to their mothers' beef consumption during pregnancy. Hum Reprod (2007) 2.26
Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab (1994) 2.21
Evidence for increasing incidence of abnormalities of the human testis: a review. Environ Health Perspect (1993) 2.09
Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology (1978) 2.07
Impaired Leydig cell function in infertile men: a study of 357 idiopathic infertile men and 318 proven fertile controls. J Clin Endocrinol Metab (2004) 2.02
Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab (1997) 1.99
Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl (2011) 1.96
A study of finger lengths, semen quality and sex hormones in 360 young men from the general Danish population. Hum Reprod (2005) 1.94
Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. J Clin Endocrinol Metab (2003) 1.81
Risk of testicular cancer in subfertile men: case-control study. BMJ (1999) 1.77
Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ (2000) 1.73
Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol (1992) 1.69
High frequency of sub-optimal semen quality in an unselected population of young men. Hum Reprod (2000) 1.69
Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet (1989) 1.63
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study. Br J Cancer (2011) 1.62
Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control (1997) 1.62
Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect (1998) 1.60
Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab (1998) 1.60
Does moderate alcohol consumption affect fertility? Follow up study among couples planning first pregnancy. BMJ (1998) 1.57
Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster. Cell Death Differ (2007) 1.55
Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum Reprod (2002) 1.55
Spontaneous abortion and physical strain around implantation: a follow-up study of first-pregnancy planners. Epidemiology (2000) 1.54
Exclusion of SNRPN as a major determinant of Prader-Willi syndrome by a translocation breakpoint. Nat Genet (1996) 1.53
Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab (1995) 1.51
A follow-up study of environmental and biologic determinants of fertility among 430 Danish first-pregnancy planners: design and methods. Reprod Toxicol (1998) 1.46
Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. Proc Natl Acad Sci U S A (1992) 1.46
Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology (2005) 1.45
Histological evaluation of the human testis--approaches to optimizing the clinical value of the assessment: mini review. Hum Reprod (2006) 1.44
[Decline in semen quality from 1930 to 1991]. Ugeskr Laeger (1993) 1.43
High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia. Mol Hum Reprod (2002) 1.43
DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours. Oncogene (2007) 1.40
Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer (1999) 1.40
Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Control (1996) 1.39
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J (Clin Res Ed) (1988) 1.39
A controlled study on serum insulin-like growth factor-I and urinary excretion of growth hormone in fibromyalgia. J Rheumatol (1995) 1.39
[Hormonal treatment of testicular retention]. Ugeskr Laeger (1991) 1.39
Insulin-like growth factor-I in celiac disease. J Pediatr Gastroenterol Nutr (1994) 1.38
[Deep-freezing of semen from cancer patients--a public task?]. Ugeskr Laeger (1995) 1.37
Risk factors for cryptorchidism and hypospadias. J Urol (1999) 1.36
Exposure to exogenous estrogens in food: possible impact on human development and health. Eur J Endocrinol (1999) 1.35
Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab (1997) 1.33
Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death. Int J Androl (1983) 1.32
Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'. Int J Androl (2008) 1.31
Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab (1997) 1.30
Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab (1999) 1.29
Testicular development in the complete androgen insensitivity syndrome. J Pathol (2006) 1.29
Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at three months of age. J Clin Endocrinol Metab (2005) 1.28
Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab (1997) 1.27
Carcinoma-in-situ of the undescended testis. Urol Clin North Am (1982) 1.26
Computer-assisted semen analysis parameters as predictors for fertility of men from the general population. The Danish First Pregnancy Planner Study Team. Hum Reprod (2000) 1.26
Testicular cancer risk in boys with maldescended testis: a cohort study. J Urol (1987) 1.25
Release of prostaglandin Es by hypothalamic tissue: evidence for their involvement in catecholamine-induced luteinizing hormone-releasing hormone release. Endocrinology (1979) 1.25
Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab (1995) 1.23
Pubertal development in Danish children: comparison of recent European and US data. Int J Androl (2006) 1.23
Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr (1997) 1.23
Possible impact of phthalates on infant reproductive health. Int J Androl (2006) 1.22
Sperm morphological defects related to environment, lifestyle and medical history of 1001 male partners of pregnant women from four European cities. Hum Reprod (2001) 1.20
Caffeine intake and fecundability: a follow-up study among 430 Danish couples planning their first pregnancy. Reprod Toxicol (1998) 1.19
High incidence of undetected neoplasia in maldescended testes. Lancet (1979) 1.18
Morphological characterization of immortalized hypothalamic neurons synthesizing luteinizing hormone-releasing hormone. Endocrinology (1991) 1.18
Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest (1995) 1.17
Metabolism of pro-luteinizing hormone-releasing hormone in immortalized hypothalamic neurons. Endocrinology (1991) 1.17
The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) (1994) 1.17
Hypothesis: exposure to endocrine-disrupting chemicals may interfere with timing of puberty. Int J Androl (2010) 1.17
Do environmental estrogens contribute to the decline in male reproductive health? Clin Chem (1995) 1.16
Catecholaminergic modulation of luteinizing hormone-releasing hormone release by median eminence terminals in vitro. Endocrinology (1979) 1.16
Reduced sweating in adults with growth hormone deficiency. Lancet (1989) 1.16
High urinary phthalate concentration associated with delayed pubarche in girls. Int J Androl (2012) 1.15
Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) (1986) 1.15
DNA damage response in human testes and testicular germ cell tumours: biology and implications for therapy. Int J Androl (2007) 1.15
The possible role of sex hormones in the development of testicular cancer. Eur Urol (1993) 1.14
Carcinoma in situ of the testis in children with 45,X/46,XY gonadal dysgenesis. J Pediatr (1985) 1.14
Double-blind Y chromosome microdeletion analysis in men with known sperm parameters and reproductive hormone profiles: microdeletions are specific for spermatogenic failure. J Clin Endocrinol Metab (2001) 1.14
A possible role for reproductive hormones in newborn boys: progressive hypogonadism without the postnatal testosterone peak. J Clin Endocrinol Metab (2000) 1.14
Preserved fertility in a non-mosaic Klinefelter patient with a mutation in the fibroblast growth factor receptor 3 gene: case report. Hum Reprod (2007) 1.13
Responses in the brain of estrogen receptor alpha-disrupted mice. Proc Natl Acad Sci U S A (1997) 1.13
Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol (1989) 1.12
Gonadal function in men with testicular cancer. Semin Oncol (1998) 1.12
Sunscreens: are they beneficial for health? An overview of endocrine disrupting properties of UV-filters. Int J Androl (2012) 1.12
Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J Clin Endocrinol Metab (2000) 1.12
Risks of testicular cancer and cryptorchidism in relation to socio-economic status and related factors: case-control studies in Denmark. Int J Cancer (1996) 1.12
Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Ann Oncol (2005) 1.11
Identification of a Y chromosome haplogroup associated with reduced sperm counts. Hum Mol Genet (2001) 1.11
Testicular cancer after vasectomy: origin from carcinoma in situ of the testis. Eur J Cancer (1993) 1.10
Declining semen quality and increasing incidence of testicular cancer: is there a common cause? Environ Health Perspect (1995) 1.10
Novel hypothalamic arachidonate products stimulate somatostatin release from the median eminence. Endocrinology (1983) 1.09
New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers. J Pathol (2006) 1.09